Generated by GPT-5-mini| Journal of Neurology, Neurosurgery, and Psychiatry | |
|---|---|
| Title | Journal of Neurology, Neurosurgery, and Psychiatry |
| Discipline | Neurology, Neurosurgery, Psychiatry |
| Abbreviation | JNNP |
| Publisher | BMJ Publishing Group |
| Frequency | Monthly |
| History | 1920–present |
| Impact | 11.0 |
Journal of Neurology, Neurosurgery, and Psychiatry is a monthly peer-reviewed medical journal covering clinical and translational research in neurology, neurosurgery, and psychiatry, associated with professional societies and academic centers. It publishes original research, reviews, and guidelines that inform practice across hospitals, universities, and specialist clinics in Europe, North America, Asia, and Australasia. The journal's articles are read by clinicians, researchers, and policymakers at institutions such as University College London, Harvard Medical School, Johns Hopkins University, Oxford University, and Mayo Clinic.
The journal was founded in the early 20th century amid developments in neurology and psychiatry shaped by figures linked to Royal College of Physicians, Royal Society of Medicine, Guy's Hospital, and St Thomas' Hospital, alongside contemporaneous publications like The Lancet, BMJ, British Medical Journal, and New England Journal of Medicine. Its editorial lineage reflects interaction with academic centers including Cambridge University, King's College London, University of Edinburgh, and research hospitals such as Addenbrooke's Hospital, National Hospital for Neurology and Neurosurgery, and Beth Israel Deaconess Medical Center. Over decades the journal responded to events involving World War I, World War II, and postwar health reforms like the National Health Service and engaged with international efforts exemplified by organizations such as World Health Organization, European Union, National Institutes of Health, and Wellcome Trust.
The journal's remit spans clinical neurology, operative neurosurgery, and psychiatric disorders, attracting submissions on topics ranging from stroke and epilepsy to dementia, movement disorders, neuroimmunology, neuro-oncology, mood disorders, and psychosis. Typical subject areas connect to research at institutions including Institute of Neurology (UCL), Sackler Faculty of Medicine, Imperial College London, Columbia University, Yale University, and UCLA. It frequently publishes studies that reference trials, registries, and consortia such as Randomized Controlled Trial, Cochrane Collaboration, ENIGMA Consortium, Alzheimer's Disease Neuroimaging Initiative, and networks that include European Stroke Organisation, American Academy of Neurology, and Royal College of Psychiatrists.
Published by BMJ Group (formerly part of British Medical Association publishing), the journal operates monthly with peer review managed by an editorial board drawn from clinicians and researchers affiliated with Mayo Clinic, Massachusetts General Hospital, Karolinska Institutet, Max Planck Society, Johns Hopkins Hospital, and Mount Sinai Hospital. Editorial policy aligns with standards from bodies such as International Committee of Medical Journal Editors, Committee on Publication Ethics, and trial registries like ClinicalTrials.gov. The journal issues position statements, consensus guidelines, and systematic reviews similar in format to documents from National Institute for Health and Care Excellence, European Medicines Agency, and Food and Drug Administration.
Articles are indexed in major services including PubMed, MEDLINE, Scopus, Web of Science, EMBASE, and databases maintained by organizations like National Library of Medicine and CrossRef. The journal's inclusion supports citation tracking in metrics from Clarivate Analytics, Google Scholar, and altmetric aggregators used by universities such as University of California, University of Toronto, and McGill University.
The journal's impact factor and citation metrics are cited by departments at King's College London, University of Oxford Medical Sciences Division, and Harvard School of Public Health when assessing research influence and tenure cases. Its articles have informed clinical guidelines from bodies including National Institute for Health and Care Excellence, European Stroke Organisation, American Psychiatric Association, and influenced regulatory decisions by European Medicines Agency and Food and Drug Administration. Reception in the professional community has involved discourse across forums such as Royal College of Physicians, European Federation of Neurological Societies, World Psychiatric Association, and specialty meetings like American Academy of Neurology Annual Meeting and Congress of the European Academy of Neurology.
The journal has published landmark reports and trials that contributed to understanding of conditions investigated by researchers at Alzheimer's Association, Parkinson's Foundation, Multiple Sclerosis Society, and clinical groups within University College London Hospitals NHS Foundation Trust and Charité – Universitätsmedizin Berlin. Notable themes include stroke thrombolysis and thrombectomy studies with links to MR CLEAN trial-era research, epilepsy treatment trials connected to centers like Cleveland Clinic, neuroimmunology findings related to work at Scripps Research, and psychiatric epidemiology referencing cohorts such as Framingham Heart Study and UK Biobank.
The journal maintains affiliations with professional organizations and receives support consistent with publishing partnerships involving BMJ Group, philanthropic organizations such as Wellcome Trust and Gates Foundation in broader research landscapes, and collaborates with academic publishers tied to Oxford University Press and Cambridge University Press in scholarly communication. Institutional subscribers include National Health Service (England), university libraries at University of Melbourne, University of Sydney, Peking University, and research institutes such as Institut Pasteur and Max Planck Institute for Human Cognitive and Brain Sciences.
Category:Medical journals